EUVIMEDEUVIMED entdecken
Leserbrief

A Case of Blinatumomab Efficacy in RAM Immunophenotype/ CBFA2T3::GLIS2 Fusion AML

Maya Ball-Burack iD, Andrew Menssen, Lisa Eidenschink Brodersen, Arun Nalla, Michael Loken, Laura Pardo, Ann Dahlberg, Chad Hudson, Soheil Meshinchi, Katherine Tarlock iD

Pediatric Blood & Cancer · 2025-12 · 72 (12)

DOI: 10.1002/pbc.32035 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 10.09.2025. Verfasst von Maya Ball-Burack und 9 weiteren Autor:innen. Beteiligte Einrichtung: Seattle Children's Hospital, Seattle, Washington, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lisa Broderson was employed by and had equity ownership in Hematologics during the time frame discussed. Michael Loken is employed by and has ownership in Hematologics. Andrew Menssen, Arun Nalla, Chad Hudson, and Laura Pardo are employees of Hematologics. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Autor:innen und Institutionen

  • Seattle Children's Hospital, Seattle, Washington, USA.
  • University of Washington School of Medicine, Seattle, Washington, USA.
  • Hematologics Inc., Seattle, Washington, USA.
  • Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Fred Hutchinson Cancer Center, Seattle, Washington, USA.

ORCID-Profile: Maya Ball-Burack, Katherine Tarlock

Zitieren

APA

Ball-Burack, M., Menssen, A., Eidenschink Brodersen, L., Nalla, A., Loken, M., Pardo, L., Dahlberg, A., Hudson, C., Meshinchi, S., & Tarlock, K. (2025). A Case of Blinatumomab Efficacy in RAM Immunophenotype/ CBFA2T3::GLIS2 Fusion AML. Pediatric Blood & Cancer, 72(12). https://doi.org/10.1002/pbc.32035

Vancouver

Ball-Burack M, Menssen A, Eidenschink Brodersen L, Nalla A, Loken M, Pardo L, et al. A Case of Blinatumomab Efficacy in RAM Immunophenotype/ CBFA2T3::GLIS2 Fusion AML. Pediatric Blood & Cancer. 2025;72(12). doi:10.1002/pbc.32035

BibTeX
@article{BallBurack2025,
  author = {Ball-Burack, Maya and Menssen, Andrew and Eidenschink Brodersen, Lisa and Nalla, Arun and Loken, Michael and Pardo, Laura and Dahlberg, Ann and Hudson, Chad and Meshinchi, Soheil and Tarlock, Katherine},
  title = {A Case of Blinatumomab Efficacy in RAM Immunophenotype/ CBFA2T3::GLIS2 Fusion AML},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  volume = {72},
  number = {12},
  doi = {10.1002/pbc.32035}
}
Kostenlos starten →